Increasing patient access to cannabis-based medicines
What next for U.S. CBD Regulations and will history repeat itself?
Broughton takes a look at the FDA’s recent announcement that it is developing a regulatory assessment for CBD products in the U.S.
All articles
Trends in the Next Generation Nicotine Product Industry: 2022
In recent years, a growing number of countries have legalized cannabis for medicinal purposes,...
What does 2023 have in store for the next-generation nicotine sector?
Day 1 of DDL opened with Federico Lavorini’s history and future of drug delivery, and it was a...
The 3rd Annual Extractables and Leachables (E&L) Conference
The Cochrane Library is a vast collection of databases which contain a variety of different types...
Smoking is one of the most efficient and effective methods of delivering a drug to the lungs; which...
In yet another twist on what is quickly becoming the PMTA saga, FDA last night ruled that the...
If you have a specific question for one of our scientific or regulatory experts, get in touch with a member of our team today.
